What to Ask Your Doctor If Your Hemoglobin or Hematocrit Is Low

A low hemoglobin or hematocrit on a routine blood count is one of the most common lab abnormalities in clinical practice—and one of the most informative. These values reflect how much oxygen-carrying protein and red cell mass are present in the blood. When they fall below normal, the cause can range from benign and easily corrected (such as dietary iron deficiency) to a sign of something that requires thorough investigation (such as blood loss, chronic disease, or a bone marrow issue). This article explains what these results mean, what the American Society of Hematology (ASH) and CDC recognize about anemia, and the questions worth raising with your clinician.

What Low Hemoglobin and Hematocrit Mean in Plain Language

Hemoglobin is the iron-containing protein inside red blood cells that binds oxygen in the lungs and carries it to tissues throughout the body. Hematocrit is the percentage of blood volume occupied by red blood cells. Both values reflect the red blood cell status of the blood.

Anemia is diagnosed when hemoglobin falls below defined thresholds. The American Society of Hematology (ASH)^[1] uses the following general reference points:

• Men: hemoglobin below approximately 13.5 g/dL
• Women: hemoglobin below approximately 12.0 g/dL

The CDC’s 2024 anemia data^[2] uses slightly different thresholds in some age-sex groups but follows the same general framework.

Hematocrit correlates closely with hemoglobin; when one is low, the other typically is as well. Other red blood cell indices from a complete blood count (CBC)—particularly the mean corpuscular volume (MCV), which reflects the average size of red blood cells—are critically important for narrowing the cause.

Anemia is not itself a diagnosis. It is a finding that requires investigation to determine the underlying cause, which then guides management.

Why It Matters: What Guidelines Say

The CDC published national anemia prevalence data^[2] from 2021–2023 showing that the overall prevalence of anemia in the U.S. population aged 2 and older was 9.3%, with significantly higher rates in females (13.0%) than males (5.5%). The CDC notes that “anemia is a major public health concern” and that “severe anemia is a risk factor for adverse health outcomes ranging from poor child development to maternal mortality.”

The American Society of Hematology (ASH) has published guidelines on iron deficiency anemia (IDA), the most common type. The ASH draft guidelines on IDA diagnosis^[3] recommend evaluating both serum ferritin and transferrin saturation (TSAT) to assess for iron deficiency, particularly in cases where inflammation may mask iron status.

The clinical significance of anemia depends on several factors:

• How low the hemoglobin is (mild versus severe)
• The rate at which it developed (rapid versus gradual)
• The underlying cause
• The person’s age, cardiovascular status, and functional reserves

Mild, slowly developing anemia from a dietary cause may cause only subtle symptoms; the same hemoglobin value developing rapidly from blood loss can cause significant cardiovascular strain.

Common Drivers and Causes at the Population Level

Anemia has many causes. Identifying which type is present is essential to treatment—giving iron to someone with vitamin B12 deficiency anemia, for example, will not help and may delay appropriate care.

Iron deficiency anemia (IDA): The most common type of anemia worldwide. It occurs when the body lacks sufficient iron to produce adequate hemoglobin. Causes include:

• Inadequate dietary iron intake (particularly relevant for vegetarians, vegans, and people with poor overall nutrition)
• Poor iron absorption (celiac disease, gastric surgery, use of antacids or PPIs)
• Chronic blood loss (menstruation, gastrointestinal bleeding from ulcers, polyps, cancer, or regular NSAID use)
• Increased iron demand (pregnancy, growth phases in children and adolescents)

IDA typically produces small, pale red blood cells—a low MCV on the CBC.

Vitamin B12 and folate deficiency anemia (megaloblastic anemia): Deficiency of B12 or folate impairs DNA synthesis, producing large, abnormal red blood cells. The MCV is elevated. Causes include dietary deficiency (particularly B12 in vegans), pernicious anemia, malabsorption, and certain medications. (See also the PMD article on low B12.)

Anemia of chronic disease (inflammation): Common in people with chronic infections, cancer, autoimmune diseases, chronic kidney disease, or heart failure. The inflammatory state suppresses normal red blood cell production and iron utilization. MCV is typically normal.

Chronic kidney disease-related anemia: The kidneys produce erythropoietin, a hormone that stimulates red blood cell production. In CKD, erythropoietin production declines, leading to anemia.

Hemolytic anemias: Red blood cells are destroyed faster than they can be replaced. Causes include autoimmune conditions, infections, mechanical heart valves, and inherited conditions such as sickle cell disease or thalassemia.

Bone marrow conditions: Aplastic anemia, myelodysplastic syndromes, and other marrow disorders reduce red blood cell production; often present with low counts across multiple cell lines (red cells, white cells, and platelets).

Bleeding: Acute or chronic blood loss—gastrointestinal, gynecological, surgical, or from other sources—depletes red blood cells faster than the marrow can replenish them.

According to the CDC^[2], anemia prevalence is higher in Black non-Hispanic individuals than in other race and Hispanic-origin groups, and increases with decreasing income, reflecting both genetic and socioeconomic factors in anemia etiology.

What Follow-Up Evaluation May Be Considered

This section is general education. Evaluation is individualized by your clinician.

When hemoglobin or hematocrit is low, a clinician typically evaluates the full CBC and red blood cell indices first:

MCV (mean corpuscular volume) is the most important initial guide:

• Low MCV (microcytic anemia): Most commonly iron deficiency or thalassemia
• Normal MCV (normocytic anemia): Most commonly anemia of chronic disease, early iron deficiency, or blood loss
• High MCV (macrocytic anemia): Most commonly B12 or folate deficiency; also associated with certain medications, alcohol use, and hypothyroidism

Iron studies: Serum ferritin (the most useful initial test; reflects iron stores), serum iron, total iron binding capacity (TIBC), and transferrin saturation (TSAT). The ASH guidelines^[3] recommend measuring both serum ferritin and TSAT when anemia of inflammation may be coexisting with iron deficiency.

Vitamin B12 and folate levels: If macrocytic anemia or other features suggest deficiency.

Reticulocyte count: Measures newly produced red blood cells; helps distinguish between production problems (low reticulocyte count) and destruction or loss.

Thyroid function (TSH): Hypothyroidism can cause anemia.

Evaluation for blood loss sources: Depending on clinical presentation, this may include stool testing for occult blood, upper or lower endoscopy (colonoscopy), or gynecological evaluation.

Peripheral blood smear: A microscopic examination of blood that can identify the shape and structure of red blood cells, providing important diagnostic clues.

Hemoglobin electrophoresis: If an inherited hemoglobin disorder (such as sickle cell disease or thalassemia) is suspected based on ethnicity, family history, or CBC pattern.

Bone marrow evaluation: Reserved for cases where other testing does not explain the anemia, or when a bone marrow disorder is suspected.

Lifestyle and Prevention Factors the Evidence Supports

Prevention and management of anemia depend on the underlying cause:

Iron-deficiency anemia:

• Dietary iron: Heme iron from meat, poultry, and fish is more bioavailable than non-heme iron from plants. Pairing plant-based iron sources (lentils, beans, spinach, fortified cereals) with vitamin C-rich foods enhances non-heme iron absorption.
• Avoiding iron absorption inhibitors: Calcium, coffee, tea, and certain medications (including antacids) can reduce iron absorption when consumed at the same time as iron-rich foods or supplements.
• Addressing blood loss sources: Managing heavy menstruation, gastrointestinal bleeding, or other ongoing blood loss is essential to resolving and preventing recurrence of iron-deficiency anemia.

Vitamin B12 and folate deficiency:

• Ensuring adequate intake through diet (animal products for B12; leafy greens, beans, and fortified foods for folate) or supplementation.
• People at risk—vegans, older adults, people taking metformin or PPIs—may benefit from routine monitoring and supplementation.

Anemia of chronic disease:

• Managing the underlying condition (diabetes, CKD, rheumatoid arthritis, etc.) is the primary approach.

General nutrition for blood health:

• A well-rounded diet that includes adequate protein, iron, B12, folate, and vitamin C supports healthy red blood cell production for most people.

The CDC notes^[4] that iron deficiency prevention focuses on dietary intake, reduction of blood loss, and targeted supplementation for high-risk groups.

Questions to Bring to Your Appointment

Choose the questions most relevant to your situation:

• What does my MCV tell you about the likely type of anemia I have?
• Should my iron levels, ferritin, B12, and folate all be checked to narrow down the cause?
• Is there a source of blood loss—gastrointestinal or gynecological—that should be evaluated?
• Does my anemia require treatment, or is it mild enough to monitor for now?
• What dietary changes would be most useful for my specific type of anemia?
• If iron deficiency is the cause, what form of iron supplementation, dosing, and duration would be appropriate?
• Could a chronic condition I have—like kidney disease, diabetes, or an inflammatory condition—be causing this?
• Should I have a colonoscopy or other gastrointestinal evaluation to look for hidden blood loss?
• Is thalassemia or another inherited red blood cell condition worth considering given my family background or ethnicity?
• Are any of my current medications contributing to this finding?
• How quickly does anemia of this degree typically improve with treatment?
• How often should I have my hemoglobin rechecked?

Red Flags Warranting Prompter Follow-Up

While mild anemia often develops gradually and can be evaluated at a routine appointment, certain features warrant more timely attention:

• Sudden or rapid onset of fatigue, shortness of breath, or palpitations, especially if worsening quickly—may suggest acute blood loss or a rapidly developing anemia
• Hemoglobin significantly below 8–9 g/dL, which typically causes more significant symptoms and may require more urgent intervention
• Blood in the stool (visible red blood or black, tarry stool), which suggests gastrointestinal bleeding and requires prompt evaluation
• Heavy vaginal bleeding beyond typical menstrual patterns
• Low hemoglobin accompanied by low white blood cell counts and low platelets on the same CBC—this pattern (pancytopenia) may suggest a bone marrow problem and warrants prompt evaluation
• Rapidly progressing fatigue, pallor, or dyspnea (shortness of breath), particularly in older adults or those with existing heart disease

Key Takeaways

• Low hemoglobin or hematocrit indicates anemia—a finding that reflects a deficiency of red blood cell mass and requires investigation to identify the cause.
• The MCV from the CBC is the most critical initial guide to anemia type: low MCV suggests iron deficiency; high MCV suggests B12 or folate deficiency; normal MCV most commonly suggests anemia of chronic disease or blood loss.
• According to the CDC, anemia affects approximately 9.3% of the US population, with females, lower-income individuals, and Black non-Hispanic individuals at higher prevalence.
• The most common cause is iron deficiency, often from dietary factors, poor absorption, or chronic blood loss—particularly heavy menstruation or occult gastrointestinal bleeding.
• ASH guidelines recommend evaluating both serum ferritin and TSAT when iron deficiency and anemia of inflammation may coexist.
• Dietary iron, B12, and folate all play roles in maintaining healthy red blood cell production; management depends entirely on the identified cause.
• Pancytopenia (low counts across all blood cell types) or rapidly progressive anemia warrants prompt clinical evaluation.

Disclaimer: This content is for general educational purposes only and is not medical advice. It does not create a doctor-patient relationship. Always talk to your licensed healthcare professional about your specific situation.

Post Views: 5